Søgning på udtrykket 'covid-19' giver 81 resultater


Dokumenter [9] Sider [2] Kalender [29] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [9]

Ændringer siden sidste udgave: 1. Simplificering af risikogrupper. 2. Skærpelse af kriterier for opstart af behandling hos indlagte patienter, f.eks. blodgas analyse før remdesivir. 3. Information om høj pris på paxlovid og højere NNT for beskyttelse mod alvorligt forløb siden primærpublikation.

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Invitation til møde den 20. maj 2022

COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: 1. Et af Paxlovid kriterierne ændret (fra ”Betydelige symptomer på COVID-19” til ”Mild eller moderat COVID-19”). 2. Døde links til infektionshygiejniske retningslinjer er fjernet, og nyt er indsat. 3. Tekst om afisolation.

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Sider [2]

… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo…

Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…


Kalender [29]

16. januar 2023, Online
14. december 2022, Online
11. oktober 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
9. februar 2022, Online
4. januar 2022, Online
7. december 2021, Online
4. november 2021, Online
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Infection
18.05.2024
. Abstract. . Purpose. Coronavirus disease 2019 (COVID-19) and non-COVID-19 community-acquired pneumonia (NC-CAP) often result in hospitalization with considerable risks of mortality, ICU treatment, and long-term morbidity. A comparative analysis of clinical outcomes in COVID-19 CAP (C-CAP) and NC-CAP may improve clinical management. . . . Methods. Using pr…
BMC Infectious Diseases
17.05.2024
…ound. Screening for tuberculosis (TB) and providing TB preventive treatment (TPT) along with antiretroviral therapy is key components of human immune deficiency virus (HIV) care. The uptake of TPT during the coronavirus disease 2019 (COVID-19) period has not been adequately assessed in Addis Ababa City Administration. This study aimed at assessing TPT uptake status among People living with HIV (PLHIV) newly initiated on antiretroviral therapy during the COVID-19 period at all public ho…
Lancet
17.05.2024
Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a dece…
PLoS One Infectious Diseases
17.05.2024
… Kymbat Sh. Tussupkaliyeva, Arman Issimov, Aisha B. Urazayeva, Zhuldyz K. Tashimova, Nadiar M. Mussin, Toleukhan Begalin, Aimeken A. Amanshiyeva, Gulaiym Zh. Nurmaganbetova, Shara M. Nurmukhamedova, Saule Balmagambetova . The scale of emergency caused by COVID-19, the ease of survey, and the crowdsourcing deployment guaranteed by the latest technology have allowed unprecedented access to data describing behavioral changes induced by the pandemic. The study aimed to present the survey results identifying at…
New England Journal of Medicine
16.05.2024
New England Journal of Medicine, Volume 390, Issue 19, Page 1835-1836, May 16/23, 2024.
Malaria Journal
16.05.2024
. Abstract. . Background. In 2020, during the COVID-19 pandemic, Médecins Sans Frontières (MSF) initiated three cycles of dihydroartemisin-piperaquine (DHA-PQ) mass drug administration (MDA) for children aged three months to 15 years within Bossangoa sub-prefecture, Central African Republic. Coverage, clinical impact, and community members perspectives were evaluated to inform the use of MDAs in humanitarian emergencies. …
Lancet Microbe
16.05.2024
Despite the aggregation of studies with differing designs, and evidence of risk of bias in some virological outcomes, this review provides evidence that treatment-induced acceleration of viral clearance within the first 5 days after treatment is a potential surrogate of clinical efficacy to prevent hospitalisation with COVID-19. This work supports the use of viral clearance as an early phase clinical trial endpoint of therapeutic efficacy.
Clinical Infectious Diseases
15.05.2024
Abstract . SARS-CoV-2 is predominantly transmitted through aerosols (i.e., airborne transmission), however, the US Centers for Disease Control and Prevention continue to recommend the use of contact precautions (a gown and gloves) for the care of patients with COVID-19. Infection prevention guidelines should reflect the current science and eliminate this wasteful practice.
PLoS One Infectious Diseases
15.05.2024
…by Mehrdad Khezri, Courtney McKnight, Chenziheng Allen Weng, Sarah Kimball, Don Des Jarlais . Background Persons who inject drugs (PWID) may be unengaged with healthcare services and face an elevated risk of severe morbidity and mortality associated with COVID-19 due to chronic diseases and structural inequities. However, data on COVID-19 vaccine uptake, particularly booster vaccination, among PWID are limited. We examined COVID-19 vaccine uptake and factors associated with booster vaccination among PWID i…
BMC Infectious Diseases
14.05.2024
. Abstract. . Background. Prioritizing prevention over treatment has been a longstanding principle in the world health system. This study aims to compare the demographic changes, mortality, clinical, and paraclinical findings of patients hospitalized in the Corona ward before and after the start of general vaccination. . . . Methods. This cr…
BMC Infectious Diseases
14.05.2024
. Abstract. . Background. Prioritizing prevention over treatment has been a longstanding principle in the world health system. This study aims to compare the demographic changes, mortality, clinical, and paraclinical findings of patients hospitalized in the Corona ward before and after the start of general vaccination. . . . Methods. This cr…
BMC Infectious Diseases
14.05.2024
. Abstract. Thromboembolic (TE) complications [myocardial infarction (MI), stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE)] are common causes of mortality in hospitalised COVID-19 patients. Therefore, this review was undertaken to explore the incidence of TE complications and mortality associated with TE complications in hospitalised COVID-19 patients from different studies. A literature search was performed using ScienceDirect and PubMed databases usi…
BMC Infectious Diseases
14.05.2024
. Abstract. Thromboembolic (TE) complications [myocardial infarction (MI), stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE)] are common causes of mortality in hospitalised COVID-19 patients. Therefore, this review was undertaken to explore the incidence of TE complications and mortality associated with TE complications in hospitalised COVID-19 patients from different studies. A literature search was performed using ScienceDirect and PubMed databases usi…
BMC Infectious Diseases
14.05.2024
. Abstract. . Background. Several models have been used to predict outbreaks during the COVID-19 pandemic, with limited success. We developed a simple mathematical model to accurately predict future epidemic waves. . . . Methods. We used data from the Ministry of Health, Labour and Welfare of Japan for newly confirmed COVID-19 cases. COVID-1…
BMC Infectious Diseases
14.05.2024
. Abstract. . Background. Several models have been used to predict outbreaks during the COVID-19 pandemic, with limited success. We developed a simple mathematical model to accurately predict future epidemic waves. . . . Methods. We used data from the Ministry of Health, Labour and Welfare of Japan for newly confirmed COVID-19 cases. COVID-1…
International Journal of Infectious Diseases
14.05.2024
Early in the pandemic, the government of China imposed strict “zero-COVID” lockdown measures that successfully prevented the spread of the SARS-CoV-2 virus throughout its populations. However, this policy required of the populace a substantial socioeconomic tradeoff. In response to widespread protests in December 2022, the Chinese government suddenly lifted its restrictions [1]. The largely unvaccinated Chinese population was subjected to a rapid increase in cases, with infection and death rates skyrock…
BMC Infectious Diseases
14.05.2024
. Abstract. . Background. Prioritizing prevention over treatment has been a longstanding principle in the world health system. This study aims to compare the demographic changes, mortality, clinical, and paraclinical findings of patients hospitalized in the Corona ward before and after the start of general vaccination. . . . Methods. This cr…
PLoS One Infectious Diseases
13.05.2024
by Keita Fukuyama, Yukiko Mori, Hiroaki Ueshima, Shiho Ito, Masaki Tanabe, Tomohiro Kuroda . Purpose The coronavirus disease 2019 (COVID-19) pandemic exhibited several different waves threatening global health care. During this pandemic, medical resources were depleted. However, the kind of medical resources provided to each wave was not clarified. This study aimed to examine the characteristics of medical care provision at COVID-19 peaks in preparation for the next pandemic. Methods Using medical insuran…
PLoS One Infectious Diseases
13.05.2024
…ble periods, overlooking the possible transformative impact of crises and the crucial role that HR managers play in crafting internal employer branding strategies. As such, this research addresses this by scrutinizing internal employer branding during the COVID-19 pandemic. Conducting in-depth interviews with 37 Belgian HR managers, we delve into the perceived challenges and opportunities that the COVID-19 crisis presented with respect to internal employer branding and its touchpoints—internal communicati…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
16.05.2024
CDC experts share what clinicians should know about COVID-19 prevention in immunocompromised patients. . CDC Expert Commentary
Morbidity and Mortality Weekly Report (MMWR)
26.04.2024
This report describes a recommendation from the Advisory Committee on Immunization Practices that all people ages ≥65 years and older receive one additional dose of any updated (2023-2024 Formula) COVID-19 vaccine.
Morbidity and Mortality Weekly Report (MMWR)
19.04.2024
This report describes COVID-19 rates, hospitalizations, and vaccination coverage among nursing home residents.
Morbidity and Mortality Weekly Report (MMWR)
19.04.2024
This report describes the duration of protection provided by the original monovalent COVID-19 vaccines.
ECDC COVID-19 updates
17.04.2024
This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection from 2021-2023.
Eurosurveillance latest updates
12.04.2024
…ropean Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI:  91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season. .
Morbidity and Mortality Weekly Report (MMWR)
12.04.2024
This report describes a review of Oregon death certificate data to assess whether young people in Oregon might be dying after receiving a COVID-19 vaccine.
Morbidity and Mortality Weekly Report (MMWR)
12.04.2024
This report describes COVID-19 vaccination coverage in the World Health Organization African Region during 2021-2023.
ECDC COVID-19 updates
8.04.2024
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living in the community.
Morbidity and Mortality Weekly Report (MMWR)
5.04.2024
This report describes the number of COVID-19 bivalent vaccine doses administered by Federal Retail Pharmacy Program partners.
Medscape Infectious Diseases
5.04.2024
Clinicians should still consider prescribing the drug to adults over age 65 or those who are immunocompromised, experts said. . Medscape Medical News
Medscape Infectious Diseases
1.04.2024
The findings of this study, which focused on the early phases of the COVID-19 pandemic, may be useful to administrators and policymakers in case of a future pandemic outbreak. . Medscape Medical News
Eurosurveillance latest updates
29.03.2024
…iod. We estimated PS and booster VE among adults and adolescents (PS only) for all products combined and for Comirnaty alone, by time since vaccination, age and chronic condition. We investigated potential bias due to correlation between COVID-19 and influenza vaccination and explored effect modification and confounding by prior SARS-CoV-2 infection. . . Results. Among adults, PS VE was 37% (95% CI: 24–47%) overall and 60% (95% CI: 44–72%), 43% (95% CI: 26–55%) and 29% (95% CI: 13–43%) 
Eurosurveillance latest updates
29.03.2024
. Background. Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic affected respiratory syncytial virus (RSV) circulation worldwide. . . Aim. To describe, for children aged 
Morbidity and Mortality Weekly Report (MMWR)
29.03.2024
This report describes the effectiveness of the updated COVID-19 vaccine in preventing hospitalizations in adults with immunocompromising conditions.
Medscape Infectious Diseases
28.03.2024
There is no increased risk for stroke during the 6 weeks following receipt of either brand of the COVID-19 bivalent vaccine, new research shows. . Medscape Medical News
Medscape Infectious Diseases
26.03.2024
Inflammatory bowel disease therapies for patients may need to be briefly halted during treatment for COVID-19, but it does not increase flares. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
21.03.2024
This report describes trends in coccidioidomycosis, histoplasmosis, and blastomycosis cases during the COVID-19 pandemic.
Medscape Infectious Diseases
21.03.2024
A study suggested that immunomodulatory medications do not increase the risk for COVID-19 related hospitalizations in patients who have received the COVID-19 vaccine. . Medscape Medical News

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

www.infmed.dk
Version: 2.12.4
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.766 s

Cookies og privatliv